LF-MFs could up-regulate the expression level of miR-486 by targetting B-cell adaptor for phosphatidylinositol 3-kinase (BCAP) and further inhibiting lung cancer through miR-486-induced autophagic cell death by inhibiting AKT/mTOR signaling pathway [43]. Here, MTOR is linked to lung carcinoma.